Post Profile






Mylan Surges After Quickly Settling With DoJ Over EpiPen Medicaid Rebates

Mylan will pay $465 million to settle with the Department of Justice over its classification of EpiPen in Medicaid rebate programs.
read more

share

Related Posts


EpiPen Maker Mylan Agrees To $465 Million Settlement With DOJ

Business & Finance : Forbes: Business

Taxpayers have been covering Medicaid rebate shortfall from company's misclassification of EpiPen.

Mylan to pay $465 million over Medicaid pricing of EpiPen

Business & Finance : Mashable: Business

Mylan will pay the Department of Justice $465 million in a settlement over its pricing and classification of the EpiPen through Medicaid, the pharmaceutical company announced Friday.  Mylan, which came under fire this summer for sys...

Mylan to pay $465 million over EpiPen Medicaid rebate dispute

Health : Reuters: Health

(Reuters) - Mylan NV on Friday said it will pay $465 million to settle the question of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment.

EpiPen Maker Mylan To Pay $465 Million For Shifty Medicaid Billing Practices

News : Huffington Post

(Reuters) - Mylan NV on Friday said it will pay $465 million to settle the question of whether misclassification of its EpiPen emergency allergy treatment resulted in underpayment of rebates to the U.S. Medicaid healthcare program. ...

Mylan to pay $465-million settlement over Medicaid EpiPen rebates

Business & Finance : LA Times: Business

Mylan will pay $465 million to settle allegations that it overbilled Medicaid for its life-saving EpiPen allergy injection. The federal government says EpiPen is a branded drug, which means Mylan should have been paying a far higher...

Comments


Copyright © 2016 Regator, LLC